Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Mitrabara Adiperdana Tbk. (MBAP) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Mitrabara Adiperdana Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Mitrabara Adiperdana Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Mitrabara Adiperdana Tbk. trades at Rp1,435 (market cap 1.79T, 57.9K 24h volume). The key difference: Mitrabara Adiperdana Tbk. is far larger — about 5.7× Diagnos Laboratorium Utama Tbk.'s market cap, and Mitrabara Adiperdana Tbk. is more actively traded (57.9K versus 41.7K). Which is the better fit depends on your goals.

DGNSMBAP
Market Cap
316.25B1.79T
Volume
41.7K57.9K
Lot
417579
Turnover
9.66M83.55M
Average Price
231.651,442.93
Value
9.66M83.55M
Indicative Equilibrium Price
2301,460
Indicative Equilibrium Volume
2.4K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
MBAP
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Mitrabara Adiperdana Tbk.

PT Mitrabara Adiperdana Tbk (the Company) was established in the Republic of Indonesia under its initial name of PT Mitrabara Adiperdana on May 29, 1992 based on the Notarial Deed No. 34 of H.A. Kadir Usman, S.H.

Read more on MBAP